Etohype 300 Tablet contains Etofylline 231mg + Theophylline 69mg, a potent bronchodilator combination widely used for managing asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. It relaxes bronchial smooth muscles, improving airflow and easing breathing difficulties.
The formulation provides sustained therapeutic action, making it suitable for maintenance therapy and long-term management of chronic respiratory conditions. Its convenient oral form ensures ease of use for adult patients.
For hospitals, respiratory clinics, and distributors, Etohype 300 Tablet is a high-demand respiratory-care product, regularly prescribed in pulmonary wards, outpatient respiratory departments, and critical-care units. Continuous use ensures stable demand and repeat orders.
Adding Etohype 300 Tablet to your portfolio strengthens your respiratory and pulmonary therapy segment, creating opportunities in hospital supply chains, pharmacy distribution, institutional orders, export markets, and third-party manufacturing. Its clinical efficacy and widespread prescription make it a valuable and profitable addition for pharmaceutical distributors.